Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Renzo Guerrini & Carmen Barba. (2021) Focal cortical dysplasia: an update on diagnosis and treatment. Expert Review of Neurotherapeutics 21:11, pages 1213-1224.
Read now
Read now
Articles from other publishers (32)
Dominika Śmiałek, Katarzyna Kotulska, Aleksandra Duda & Sergiusz Jóźwiak. (2023) Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age. Neurology and Therapy 12:3, pages 931-946.
Crossref
Crossref
Ali A. Asadi-Pooya. (2023) Precision Medicine in Epilepsy Management; GET Application (Gene, Epilepsy, Treatment). Clinical Neuropharmacology 46:3, pages 95-97.
Crossref
Crossref
Catarina Ester Gomes Menezes, Débora Lopes dos Santos, Erick Santos Nery, Evelin Duarte Serpa, Lécio Aragão Souza Morais, Lucas Santana Dutra, Marcos Baruch Portela Filho & Julieta Sobreira Goes. (2023) Everolimus as a therapeutic option in refractory epilepsy in children with tuberous sclerosis: a systematic review. Arquivos de Neuro-Psiquiatria 81:04, pages 392-398.
Crossref
Crossref
Jorge J. Asconapé. 2023. Discoveries in Pharmacology. Discoveries in Pharmacology
241
247
.
Emma N.M.M. von Scheibler, Agnies M. van Eeghen, Tom J. de Koning, Mark L. Kuijf, Janneke R. Zinkstok, Annelieke R. Müller, Thérèse A.M.J. van Amelsvoort & Erik Boot. (2022) Parkinsonism in Genetic Neurodevelopmental Disorders: A Systematic Review. Movement Disorders Clinical Practice 10:1, pages 17-31.
Crossref
Crossref
Karen Litwa. (2022) Shared mechanisms of neural circuit disruption in tuberous sclerosis across lifespan: Bridging neurodevelopmental and neurodegenerative pathology. Frontiers in Genetics 13.
Crossref
Crossref
Mitchell Hunter-Dickson, Patrick Wu, Akshay Athavale & Amanda Ying Wang. (2022) Management of Renal Angiomyolipomas in Tuberous Sclerosis Complex: A Case Report and Literature Review. Journal of Clinical Medicine 11:20, pages 6084.
Crossref
Crossref
Alan Talevi. (2022) Antiseizure medication discovery: Recent and future paradigm shifts. Epilepsia Open 7:S1.
Crossref
Crossref
Bethany K Terry, Raehee Park, Seo-Hee Cho, Peter B Crino & Seonhee Kim. (2022) Abnormal activation of Yap/Taz contributes to the pathogenesis of tuberous sclerosis complex. Human Molecular Genetics 31:12, pages 1979-1996.
Crossref
Crossref
Nathan A. Shlobin & Josemir W. Sander. (2022) Current Principles in the Management of Drug-Resistant Epilepsy. CNS Drugs 36:6, pages 555-568.
Crossref
Crossref
Aleksandr N. Shestakov, Murat B. Supurgibekov, Elena A. Shpakova & Dmitrii E. Sharkov. (2021) Optimization of the Everolimus Intermediate Preparation Process: Impurity Identification Followed by One-Pot Transformation to the Desired Product. Organic Process Research & Development 26:1, pages 222-233.
Crossref
Crossref
Rong Ma & Loganathan Karthik. 2022. Actinobacteria. Actinobacteria
265
276
.
Wolfgang Löscher. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
3413
3439
.
Emilio Perucca. (2021) The pharmacological treatment of epilepsy: recent advances and future perspectives. Acta Epileptologica 3:1.
Crossref
Crossref
Wolfgang Löscher. (2021) Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy. Frontiers in Pharmacology 12.
Crossref
Crossref
Wolfgang Löscher & Pavel Klein. (2021) The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond. CNS Drugs 35:9, pages 935-963.
Crossref
Crossref
Eimear Kirby, Shiraz Elbashier, Clodagh Sweeney, Eilish Twomey, Kathleen Gorman, Michael Riordan & Atif Awan. (2021) Unexpected diagnosis in a child with hemolytic uremic syndrome: Answers. Pediatric Nephrology 36:9, pages 2711-2714.
Crossref
Crossref
Martina Proietti Onori, Linda M. C. Koene, Carmen B. Schäfer, Mark Nellist, Marcel de Brito van Velze, Zhenyu Gao, Ype Elgersma & Geeske M. van Woerden. (2021) RHEB/mTOR hyperactivity causes cortical malformations and epileptic seizures through increased axonal connectivity. PLOS Biology 19:5, pages e3001279.
Crossref
Crossref
Laurent M. Willems, Adam Strzelczyk & Felix Rosenow. (2021) Everolimus als krankheitsspezifische Therapieoption bei mit tuberöser Sklerose assoziierter, therapierefraktärer Epilepsie – ein systematischer ÜberblickEverolimus as disease-specific treatment option in tuberous sclerosis complex-associated drug refractory epilepsy—a systematic review. Zeitschrift für Epileptologie 34:2, pages 168-174.
Crossref
Crossref
Xin Tang, Gabrielle Angst, Michael Haas, Fuchun Yang & Chenran Wang. (2021) The Characterization of a Subependymal Giant Astrocytoma-Like Cell Line from Murine Astrocyte with mTORC1 Hyperactivation. International Journal of Molecular Sciences 22:8, pages 4116.
Crossref
Crossref
Vijendra Sharma, Rapita SoodDanning Lou, Tzu-Yu HungMaxime Lévesque, Yelin Han, Jeremy Y. Levett, Peng Wang, Shravan Murthy, Shannon TansleySiyan WangNadeem SiddiquiSoroush Tahmasebi, Kobi Rosenblum, Massimo Avoli, Jean-Claude Lacaille, Nahum Sonenberg & Arkady Khoutorsky. (2021) 4E-BP2–dependent translation in parvalbumin neurons controls epileptic seizure threshold. Proceedings of the National Academy of Sciences 118:15.
Crossref
Crossref
Cecilie Johannessen Landmark, Heidrun Potschka, Stéphane Auvin, Jo M. Wilmshurst, Svein I. Johannessen, Dorothée Kasteleijn‐Nolst Trenité & Elaine C. Wirrell. (2021) The role of new medical treatments for the management of developmental and epileptic encephalopathies: Novel concepts and results. Epilepsia 62:4, pages 857-873.
Crossref
Crossref
Sophie Schlabitz, Laura Monni, Alienor Ragot, Matthias Dipper-Wawra, Julia Onken, Martin Holtkamp & Pawel Fidzinski. (2021) Spatiotemporal Correlation of Epileptiform Activity and Gene Expression in vitro. Frontiers in Molecular Neuroscience 14.
Crossref
Crossref
Jakob Stockinger, Adam Strzelczyk, Andrea Nemecek, Michal Cicanic, Frank Bösebeck, Christian Brandt, Hajo Hamer, Tassanai Intravooth & Bernhard J. Steinhoff. (2021) Everolimus in adult tuberous sclerosis complex patients with epilepsy: Too late for success? A retrospective study. Epilepsia 62:3, pages 785-794.
Crossref
Crossref
Christina Gross. (2020) Fil-lamin-ing in the Gap in Cortical Dysplasia. Epilepsy Currents 21:1, pages 51-53.
Crossref
Crossref
Wolfgang Löscher. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
27
.
Wolfgang Löscher. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
27
.
Wardiya Afshar Saber & Mustafa Sahin. (2020) Recent advances in human stem cell-based modeling of Tuberous Sclerosis Complex. Molecular Autism 11:1.
Crossref
Crossref
Alessia Di Nardo, Isadora Lenoël, Kellen D. Winden, Alina Rühmkorf, Meera E. Modi, Lee Barrett, Ebru Ercan-Herbst, Pooja Venugopal, Robert Behne, Carla A.M. Lopes, Robin J. Kleiman, Mónica Bettencourt-Dias & Mustafa Sahin. (2020) Phenotypic Screen with TSC-Deficient Neurons Reveals Heat-Shock Machinery as a Druggable Pathway for mTORC1 and Reduced Cilia. Cell Reports 31:12, pages 107780.
Crossref
Crossref
Rubén D. Castro-Torres, Mónica E. Ureña-Guerrero, Lilia M. Morales-Chacón, Lourdes Lorigados-Pedre, Bárbara Estupiñan-Díaz, Luisa Rocha, Sandra Orozco-Suárez, Martha C. Rivera-Cervantes, Mario Alonso-Vanegas & Carlos Beas-Zárate. (2020) New Aspects of VEGF, GABA, and Glutamate Signaling in the Neocortex of Human Temporal Lobe Pharmacoresistant Epilepsy Revealed by RT-qPCR Arrays. Journal of Molecular Neuroscience 70:6, pages 916-929.
Crossref
Crossref
A. V. Grigoryeva, M. Yu. Dorofeeva, V. S. Perminov & E. D. Belousova. (2020) A retrospective analysis of the efficacy and tolerability of treatment with everolimus in treatment-refractory epilepsy associated with tuberous sclerosis. Almanac of Clinical Medicine 48:1, pages 1-6.
Crossref
Crossref
Stephen F. Traynelis, Dennis Dlugos, David Henshall, Heather C. Mefford, Michael A. Rogawski, Kevin J. Staley, Penny A. Dacks, Vicky Whittemore & Annapurna Poduri. (2020) Epilepsy Benchmarks Area III: Improved Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects. Epilepsy Currents 20:1_suppl, pages 23S-30S.
Crossref
Crossref